Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
6,134
Total Claims
$427K
Drug Cost
412
Beneficiaries
$1,038
Cost/Patient
Risk Score Breakdown 49/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+1406%
Opioid rate vs peers
57.0% vs 3.8% avg
-12%
Cost per patient vs peers
$1,038 vs $1,174 avg
-13%
Brand preference vs peers
7.7% vs 8.9% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
Opioid Prescribing
57.0%
Opioid Rate
3,494
Opioid Claims
$244K
Opioid Cost
29.4%
Long-Acting Rate
This provider's opioid prescribing rate of 57.0% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 472 claims · $250K
Generic: 5,662 claims · $178K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl | 128 | $71K |
| Rimegepant Sulfate | 47 | $56K |
| Oxycodone Myristate | 73 | $47K |
| Oxycodone Hcl/Acetaminophen | 1,266 | $36K |
| Naloxegol Oxalate | 54 | $24K |
| Pregabalin | 310 | $22K |
| Gabapentin | 908 | $19K |
| Erenumab-Aooe | 22 | $17K |
| Fentanyl | 148 | $16K |
| Hydrocodone/Acetaminophen | 753 | $15K |
| Hydromorphone Hcl | 24 | $13K |
| Morphine Sulfate | 434 | $12K |
| Buprenorphine | 40 | $10K |
| Lubiprostone | 16 | $5,521 |
| Buprenorphine Hcl | 11 | $4,212 |
Prescribing Profile
39
Unique Drugs
49.0
Anomaly Score
Patient Profile
65
Avg Age
69%
Female
1.96
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About